Data from the Ministry of Commerce of China
A: China notes that the U.S. Department of Commerce has issued two announcements, one of which removes 25 Chinese entities from the "unverified list", which is welcomed by China and shows that the two sides can resolve their specific concerns through communication on the basis of mutual respect; the other one removes 36 Chinese entities from the "unverified list" and puts them on the "entity list" of U.S. export control. Another announcement put 36 Chinese entities on the U.S. export control "entity list", which China firmly opposes.
In recent years, the U.S. side has ignored the fact that Chinese and U.S. enterprises carry out normal commercial transactions and trade exchanges, disregarded the strong voices of the industry in China and the U.S., generalized the concept of national security, abused the export control and other measures, and used the power of the state to expand the crackdown on Chinese enterprises and institutions, which is typical of the distortion of the market and the practice of economic bullying.
The U.S. side's frequent inclusion of Chinese enterprises in the "Entity List" interferes with normal economic and trade exchanges and cooperation between Chinese and U.S. enterprises, violates the laws of the market, undermines market rules and the international economic and trade order, affects the stability of the global industrial chain supply chain, and jeopardizes the interests of global peace and development. This is not favorable to China, not favorable to the United States, and not favorable to the whole world.
China maintains that export control should abide by the principles of fairness, reasonableness and non-discrimination, and should not jeopardize the legitimate rights and interests of other countries in the peaceful use of export-controlled items, nor should it set up obstacles to the rational use of the fruits of scientific and technological progress to promote development, carry out normal international scientific and technological exchanges and economic and trade cooperation, and safeguard the safe and smooth operation of the global industrial chain supply chain.
China hopes that the U.S. side will immediately stop its wrong practices and return to the right path of maintaining the rules of the multilateral trading system based on the World Trade Organization. At the same time, in response to the U.S. behavior, China will take necessary measures to resolutely safeguard the legitimate and legitimate rights and interests of Chinese enterprises and institutions.
Extended reading:
The United States once again suppressed ZTE Huawei but in the field of medical appliances to China hurt
The United States of America on Chinese technology companies to suppress, can be described as everything. Recently, the United States has introduced new norms, of course, deducted or "threat to U.S. national security" crooked hat. However, China is not without constraints on the U.S. In the medical equipment, China let the U.S. and the European Union can do nothing.
November 25, the U.S. Federal Communications Commission said it had voted unanimously to adopt new norms that would prohibit the import or sale of certain technology products that pose a security risk to U.S. critical infrastructure. It was the latest in years of escalating U.S. restrictions on Chinese technology, which began under Trump and were renewed by the Biden administration.
Rosenworcel, a Democrat who chairs the commission, said in a statement, "The FCC is committed to protecting U.S. national security by ensuring that untrustworthy communications equipment is not authorized for use within our borders, and we will continue to do this work."
Under the new specifications, the U.S. will ban the sale of communications equipment made by Huawei and ZTE and restrict the use of some Chinese-made video surveillance systems, including products from Hikvision, Dahua, and Hainengda, on the grounds that they pose an unacceptable risk to U.S. national security.
The FCC's order applies to future equipment authorizations, though the agency left open the possibility that it could revoke previous authorizations.
Communications commissioner Carr, a member of the **** and GOP, tweeted, "As a result of our order, no new Huawei or ZTE equipment can be authorized. Nor can any new Dahua, Hikvision, or Hynectar equipment be approved unless they assure the FCC that their equipment will not be used for public **** security, government facility security, and other national security purposes."
The U.S. is suppressing China in the technology sector, but it's hurting for medical devices.
China is one of Europe's major trading partners in medical devices and equipment, accounting for 12 percent of exports to the European medical equipment market in 2021 alone. But the European Union and the United States argue that China is pursuing protectionist policies in the medical device sector, claiming that China takes various measures to support its domestic medical device industry.
As China is not a party to the World Trade Organization's Agreement on Government Procurement (GPA), it has only been able to negotiate verbally with China.
Pharmaceuticals and medical devices will reportedly be on the agenda of the 3rd meeting of the Committee on Trade and Technology between the U.S. government and the European Union's executive committee, which will be held in Washington on Dec. 5 next year.
The Trade and Technology Committee, established in June 2021, is an initiative organization that provides a permanent platform for transatlantic cooperation on key global trade, economic and technology issues. In the draft, the U.S. and the European Union expressed "concern about the threat posed by a range of non-market policies and practices," such as in the area of medical devices. Medical device importers report that China's tenders, which were previously open to imports, now specifically require the use of domestic products.
In response, the EU's executive committee said it had been expressing concerns about market release barriers to the Chinese authorities.
The draft from the Committee on Trade and Technology says the U.S. and EU have analyzed and exchanged relevant data and examined the market share of U.S. and EU medical device companies in China to understand the challenges of the impact on U.S. and EU companies.
In fact, it's useless for the US and EU to express any more concern that the Chinese government has its own reasons for supporting its domestic medical device industry, which is mostly for the benefit of the public. Take the cardiac stent for example, the original a cardiac stent 20,000 yuan, now the state through centralized purchasing, increase production and other measures, a cardiac stent of the same quality down to a few hundred dollars a, the quality of domestic stents is not inferior to the imported stents, so why do people have to use the price of super-expensive imported cardiac stents it?